Professional Documents
Culture Documents
Miguel S. Datijan
EAC 3rd Year BSN
Name of Drug
Generic Name:
Classification
Pharmacologic Class:
Mechanism of Action
Therapeutic:
Indication
General Indication:
Ranitidine
Gastrointestinal agent:
Competitive inhibition of
Trade/Brand Name:
histamine at H2
Zantac
antagonist)
Patients Dose: 10 mg
Pregnancy Risk
(For Pediatric)
Category:
maximum: 300 mg /
Pregnancy Risk B
day
concentration are
Source:www.unilab.com
doses
pepsin secretion,
Route(s) of
pentagastrin stimulated
Administration: Oral,
Parenteral: IM, IV
or serum gastrin
Source: nurseslabs.com
Pharmacokinetics:
Onset: 30 minutes
Peak: 1-3 hours
Duration: 6-8 hours
1 |EAC
lav-m2013
Contraindication
Contraindication:
H2-blockers may be
contraindicated in : Renal disease,
hepatic disease: the H2-blocker
may build up in the bloodstream,
which increases the risk of side
effects. Immunodeficiency :
Side Effects
Drowsiness
Dizziness
Decreased Sex drive,
impotence or difficulty
having an orgasm
Swollen or tender breasts (in
men)
Stomach pain
Nursing Responsibilities
* Inform patient that the
medication may cause
drowsiness, dizziness or fatigue
(Use caution when driving or
engaging in task requiring
alertness)
lav-m2013
Adverse Effect
Constipation
Diarrhea
Fatigue
Headache
Insomnia
Muscle pain
Nausea
Vomiting
Agitation
Anemia
Depression
Easy bruising or bleeding
3 |EAC
lav-m2013